why choose us

First received: March 11, 2025

Clinical Trial: A Pharmacokinetics (PK) Study in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Blepharoptosis

Study Type: INTERVENTIONAL


Official Title: A Multiple-Dose Pharmacokinetics (PK) Study of STN1013800 in Healthy Adults

Brief Summary: This is to characterize STN1013800 active ingredient bioavailability following multiple-dose ocular administration of STN1013800 to both eyes in healthy adults.It is a PK study with screening period of up to 28 days + dosing period of 7 days + Follow-up period of 2 days.At present, there are no medicines for the treatment of acquired blepharoptosis in China.Therefore, efficacy and safety phase III study is also currently being conducted.

Read more